Roivant Sciences Ltd. (ROIV) — Financial statements
Income statement, balance sheet, and cash flow for Roivant Sciences Ltd. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 29↓11.2% | 33↓46.6% | 61↑10.8% | 55↑132.3% | 24 | |
| Cost of Revenue | 0.91↓43.0% | 2↓87.8% | 13↑46.4% | 9↑335.9% | 2 | |
| Gross Profit | 28↓9.6% | 31↓35.4% | 48↑4.0% | 46↑113.1% | 22 | |
| Operating Expenses | ||||||
| R&D Expenses | 550↑25.1% | 440↓16.2% | 525↑8.7% | 483↑104.1% | 237 | |
| General & Administrative Expenses | 591↑42.1% | 416↓30.7% | 601↓22.5% | 775↑198.2% | 260 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 591↑42.1% | 416↓30.7% | 601↓22.5% | 775↑198.2% | 260 | |
| Other Expenses | -110↑97.9% | -5,322↓5544.5% | 98↓30.1% | 140↓76.5% | 596 | |
| Operating Expenses | 1,031↑123.1% | -4,466↓465.0% | 1,223↓12.5% | 1,398↑27.9% | 1,093 | |
| Total Costs & Expenses | 1,032↑123.1% | -4,464↓461.0% | 1,237↓12.1% | 1,407↑28.5% | 1,095 | |
| Operating Results | ||||||
| Operating Income | -1,003↓122.3% | 4,497↑482.6% | -1,175↑13.0% | -1,352↓26.2% | -1,071 | |
| Depreciation & Amortization | 14↓36.1% | 22↑16.9% | 19↑217.9% | 6↓96.6% | 175 | |
| EBITDA | -1,100↓37.0% | -803↑31.8% | -1,178↓29.3% | -911↓26.4% | -721 | |
| EBIT | -1,114↓35.0% | -825↑31.1% | -1,197↓30.6% | -917↓2.3% | -896 | |
| Interest & Other Income | ||||||
| Net Interest Income | 258↑131.4% | 112↑2548.2% | 4↑163.2% | -7↓379.7% | -1 | |
| Interest Income | 258↑76.5% | 146↑355.0% | 32↑8622.0% | 0.37↓74.0% | 1 | |
| Interest Expense | 0.00↓100.0% | 35↑24.3% | 28↑297.2% | 7↑150.7% | 3 | |
| Non-Operating Income | 110↓97.9% | 5,322↑24598.2% | 22↑105.0% | -435↓148.3% | -175 | |
| Other Income / Expenses | 322↑354.2% | 71↑243.0% | -50↓111.6% | 428↑148.3% | 172 | |
| Income Before Tax | -682↓114.9% | 4,568↑472.9% | -1,225↓32.6% | -924↓2.8% | -899 | |
| Income Tax Expense | 48↑124.0% | 22↑314.3% | 5↑1306.5% | 0.37↓78.1% | 2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -730↓116.1% | 4,546↑469.6% | -1,230↓33.1% | -924↓2.7% | -900 | |
| Net Income from Discontinued Operations | 373↑218.4% | -315↓375.1% | 115 | 0.00 | 0.00 | |
| Net Income | -172↓104.0% | 4,349↑531.0% | -1,009↓19.4% | -845↓4.5% | -809 | |
| Bottom-Line Net Income | -172↓104.0% | 4,349↑531.0% | -1,009↓19.4% | -845↓4.5% | -809 | |
| EPS (Basic) | -0.24↓104.3% | 5.55↑490.8% | -1.42↓12.7% | -1.26↓6.8% | -1.18 | |
| EPS (Diluted) | -0.24↓104.6% | 5.23↑468.3% | -1.42↓12.7% | -1.26↓6.8% | -1.18 | |
| Weighted Average Shares | 725↓7.4% | 783↑9.9% | 713↑6.4% | 670↓2.2% | 685 | |
| Weighted Average Diluted Shares | 725↓12.7% | 831↑16.6% | 713↑6.4% | 670↓2.2% | 685 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.